CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
Malaria remains a significant cause of morbidity and mortality in sub-Saharan Africa. An efficacious vaccine will be an essential part of attempts to eradicate the disease. A vaccine strategy targeting multiple stages lifecycle stages may be required to achieve a high level of efficacy. In a series...
Main Authors: | Ewer (nee Russell), K, Bowyer, G, Grobbelaar, A, Rampling, T, Venkatraman, N, Morelle, D, Ballou, R, Hill, A |
---|---|
Format: | Journal article |
Published: |
Frontiers Media
2018
|
Similar Items
-
Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
by: Rampling, T, et al.
Published: (2016) -
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
by: Aroosa Younis Nadeem, et al.
Published: (2022-04-01) -
Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
by: Rampling, T, et al.
Published: (2018) -
RTS,S/AS01 malaria vaccine in African children.
by: Hill, A
Published: (2012) -
A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
by: Suresh Pallikkuth, et al.
Published: (2020-04-01)